Yi Yang

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.

H. Kohrt, R. Pierce, H. Maecker, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Durable Responses with Pembrolizumab in Relapsed/Refractory Mycosis Fungoides and Sézary Syndrome: Final Results from a Phase 2 Multicenter Study

H. Kohrt, H. Maecker, J. Yearley, 2018, Blood.

Pembrolizumab for Treatment of Relapsed/Refractory Mycosis Fungoides and Sezary Syndrome: Clinical Efficacy in a Citn Multicenter Phase 2 Study

Ash A. Alizadeh, H. Kohrt, H. Maecker, 2016 .